Consistent with this finding, we derived a transcriptomic signature of IRAK4 overexpression from 183 MDS samples (Figure 5—figure supplement 2) and compared it to a published leukemic stem cell signature (Eppert et al., 2011) and found significant concordance (Figure 5F). This evidence concerns the gene IRAK4 and myelodysplastic syndrome.